Introduction to Chemoinformatics in Drug Discovery - A Personal View

Chemoinformatics in Drug Discovery

Volumn 23, Issue , 2005, Pages 1-22

  Marshall, Garland R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Active analog approach; Active site modeling; Chemoinformatics in drug discovery; Graph theory and molecular numerology; High throughput screens; Pharmacophore; PLS CoMFA; Protein structure prediction; Structure based drug design

Indexed keywords

BIOCHIPS; FORECASTING; PHARMACODYNAMICS; PROTEINS; THROUGHPUT;

ACTIVE-ANALOG APPROACH; ACTIVE-SITE MODELING; DRUG DISCOVERY; HIGH-THROUGHPUT SCREENS; PHARMACOPHORES; PLS/COMFA; PROTEIN STRUCTURE PREDICTION; STRUCTURE BASED DRUG DESIGNS;

GRAPH THEORY;

EID: 84867590753     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527603743.ch1     Document Type: Editorial

References (85)

1. BROWN, F. Chemoinformatics: What is it and How does it impact drug discovery. Annu. Rep. Med. Chem. 1998, 33, 375-384.
2. HANN, M., GREEN, R. Chemoinformatics - a new name for an old problem? Curr. Opin. Chem. Biol. 1999, 3, 379-383.
3. RITCHIE, T. Chemoinformatics; manipulating chemical information to facilitate decision-making in drug discovery. Drug Discovery Today 2001, 6(16), 813-814.
4. JOHNSON, D.E., BLOWER, P.E., Jr, MYATT, G.J., WOLFGANG, G.H. Chem-tox informatics: data mining using a medicinal chemistry building block approach. Curr. Opin. Drug Disc. Dev. 2001, 4(1), 92-101.
5. OPREA, T.I., GOTTFRIES, J. Chemography: the art of navigating in chemical space. J. Comb. Chem. 2001, 3, 157-166.
6. OPREA, T.I. Chemical space navigation in lead discovery. Curr. Opin. Chem. Biol. 2002, 6(3), 384-389.
7. LEACH, A.R., GILLET, V.J. An Introduction to Chemoinformatics. Kluwer Academic Publishers, Dordrecht, Netherlands, 2003, 259.
8. HO, C.M., MARSHALL, G.R. DBMAKER: a set of programs to generate threedimensional databases based upon user-specified criteria. J. Comput.-Aided Mol. Des. 1995, 9(1), 65-86.
9. PEARLMAN, R.S. CONCORD User's Manual. Tripos Associates, St. Louis, MO, 1992.
10. ALLEN, F.H., MOTHERWELL, W.D. Applications of the Cambridge structural database in organic chemistry and crystal chemistry. Acta Crystallogr, Sect B 2002, 58(Pt 3 Pt 1), 407-422.
11. ALLEN, F.H., DAVIES, J.E., GALLOY, J.J., JOHNSON, O., KENNARD, O., MACREA, C.F., MITCHELL, E.M., MITCHELL, G.F., SMITH, J.M., WATSON, D.G. The developments of versions 3 and 4 of the Cambridge database system. J. Chem. Inf. Comput. Sci. 1991, 31, 187-204.
12. ABOLA, E.E., BERNSTEIN, F.C., KOETZLE, T.F. The protein data bank. In The Role of Data in Scientific Progress, GLAESER, P.S. (ed.) Elsevier, New York, 1985.
13. BARRY, C.D., ELLIS, R.A., GRAESSER, S., MARSHALL, G.R. Display and manipulation in three dimensions. In Pertinent Concepts in Computer Graphics, FAIMAN, M. NIEVERGELT, J. (Eds). University of Illinois Press, Chicago, IL, 1969, 104-153.
14. FUJITA, T., IWASA, J., HANSCH, C. A new substituent constant, π, derived from partition coefficients. J. Am. Chem. Soc. 1964, 86(December 5), 5175-5180.
15. HANSCH, C., LEO, A. Substituent Constants for Correlation Analysis in Chemistry and Biology. Wiley & Sons, New York, 1979.
16. GOODFORD, P.J. Drug design by the method of receptor fit. J. Med. Chem. 1984, 27(5), 557-564.
17. RILEY, D.P. Rational design of synthetic enzymes and their potential utility as human pharmaceuticals: development of manganese(II)-based superoxide dismutase mimics. Adv. Supramol. Chem. 2000, 6, 217-244.
18. RILEY, D.P., HENKE, S.L., LENNON, P.J., ASTON, K. Computer-aided design (CAD) of synzymes: use of molecular mechanics (MM) for the rational design of superoxide dismutase mimics. Inorg. Chem. 1999, 38(8), 1908-1917.
19. MOTOC, I., MARSHALL, G.R., LABANOWSKI, J. Molecular shape descriptors. 3. Steric mapping of biological receptor. Z. Naturforsch. 1985, 40a, 1121-1127.
20. MOTOC, I., MARSHALL, G.R. Molecular shape descriptors. 2. Quantitative structure-activity relationships based upon three-dimensional molecular shape descriptor. Z. Naturforsch. 1985, 40a, 1114-1120.
21. MOTOC, I., MARSHALL, G.R., DAMMKOEHLER, R.A., LABANOWSKI, J. Molecular shape descriptors. 1. Three-dimensional molecular shape descriptor. Z. Naturforsch. 1985, 40a, 1108-1113.
22. BECKETT, A.H., CASEY, A.F. Synthetic analgesics: stereochemical considerations. J. Pharm. Pharmacol. 1954, 6, 986-999.
23. KIER, L.B., ALDRICH, H.S. A theoretical study of receptor site models for trimethylammonium group interactions. J. Theor. Biol. 1974, 46, 529-541.
24. GUND, P., WIPKE, W.T., LANGRIDGE, R. Computer searching of a molecular structure file for pharmacophoric patterns. Comput. Chem. Res. Educ. Technol. 1974, 3, 5-21.
25. GUND, P. Three-dimensional pharmacophoric pattern searching. Prog. Mol. Subcell. Biol. 1977, 11, 117-143.
26. HUMBER, L.G., BRUDERLIN, F.T., PHILIPP, A.H., GOTZ, M., VOITH, K. Mapping the dopamine receptor. 1. Features derived from modifications in ring E of the neuroleptic butaclamol. J. Med. Chem. 1979, 22, 761-767.
27. MARSHALL, G.R., BARRY, C.D., BOSSHARD, H.E., DAMMKOEHLER, R.A., DUNN, D.A. The conformational parameter in drug design: the active analog approach. In Computer-Assisted Drug Design, OLSON, E.C. CHRISTOFFERSEN, R.E. (eds). American Chemical Society, Washington, DC, 1979, 205-226.
28. MARSHALL, G.R., BARRY, C.D. Functional representation of molecular volume for computer-aided drug design. Abstr. Amer. Cryst. Assoc., Honolulu, Hawaii 1979.
29. SUFRIN, J.R., DUNN, D.A., MARSHALL, G.R. Steric mapping of the L-methionine binding site of ATP: L-methionine S-adenosyltransferase. Mol. Pharmacol. 1981, 19, 307-313.
30. WEAVER, D.C., BARRY, C.D., MCDANIEL, M.L., MARSHALL, G.R., LACY, P.E. Molecular requirements for recognition at glucoreceptor for insulin release. Mol. Pharmacol. 1979, 16(2), 361-368.
31. KLUNK, W.E., KALMAN, B.L., FERRENDELLI, J.A., COVEY, D.F. Computer-assisted modeling of the picrotoxinin and γ-butyrolactone receptor site. Mol. Pharmacol. 1982, 23, 511-518.
32. RUTLEDGE, L.D., PERLMAN, J.H., GERSHENGORN, M.C., MARSHALL, G.R., MOELLER, K.D. Conformationally restricted TRH analogs: a probe for the pyroglutamate region. J. Med. Chem. 1996, 39(8), 1571-1574.
33. SIMPSON, J.C., HO, C.M.C., SHANDS, E.F.B., GERSHENGORN, M.C., MARSHALL, G.R., MOELLER, K.D. Conformationally restricted TRH analogs: constraining the pyroglutamate region. Bioorg. Med. Chem. 2002, 10, 291-302.
34. SLOMCZYNSKA, U., CHALMERS, D.K., CORNILLE, F., SMYTHE, M.L., BEUSEN, D.D., MOELLER, K.D., MARSHALL, G.R. Electrochemical cyclization of dipeptides to form novel bicyclic, reverse-turn peptidomimetics. 2. Synthesis and conformational analysis of 6,5-bicyclic systems. J. Org. Chem. 1996, 61(4), 1198-1204.
35. TONG, Y.S., OLCZAK, J., ZABROCKI, J., GERSHENGORN, M.C., MARSHALL, G.R., MOELLER, K.D. Constrained peptidomimetics for TRH: cis-peptide bond analogs. Tetrahedron 2000, 56(50), 9791-9800.
36. DEPRIEST, S.A., MAYER, D., NAYLOR, C.B., MARSHALL, G.R. 3D-QSAR of angiotensin-converting enzyme and thermolysin inhibitors: a comparison of CoMFA models based on deduced and experimentally determned active site geometries. J. Am. Chem. Soc. 1993, 115, 5372-5384.
37. ANDREWS, P.R., CARSON, J.M., CASELLI, A., SPARK, M.J., WOODS, R. Conformational analysis and active site modelling of angiotensin-converting enzyme inhibitors. J. Med. Chem. 1985, 28(3), 393-399.
38. MAYER, D., NAYLOR, C.B., MOTOC, I., MARSHALL, G.R. A unique geometry of the active site of angiotensin-converting enzyme consistent with structure-activity studies. J. Comput.-Aided Mol. Des. 1987, 1(1), 3-16.
39. NATESH, R., SCHWAGER, S.L., STURROCK, E.D., ACHARYA, K.R. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 2003, 421(6922), 551-554.
40. MARSHALL, G.R., CRAMER III, R.D. Three-dimensional structure-activity relationships. Trends Pharmacol. Sci. 1988, 9, 285-289.
41. CRAMER III, R.D., MILNE, M. The lattice model: a general paradigm for shaperelated structure/activity correlation. In 19th National Meeting of the American Chemical Society. American Chemical Society, Washington, DC, 1979, COMP 44.
42. CRAMER III, R.D., PATTERSON, D.E., BUNCE, J.D. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988, 110(18), 5959-5967.
43. WOLD, S., ABANO, C., DUNN III, W.J., ESBENSEN, K., HELLBERG, S., JOHANSSON, E., LINDBERG, W., SJOSTROM, M. Modelling data tables by principal components and PLS: class patterns and quantitative predictive relations. Analysis, 1984, 12(10), 477-485.
44. CRAMER III, R.D., BUNCE, J., PATTERSON, D., FRANK, I. Crossvalidation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies. Quantum Struct. Act. Relat. 1988, 7, 18-25.
45. CRAMER, I., RICHARD, D. BC(DEF) parameters. 1. The intrinsic dimensionality of intermolecular interactions in the liquid state. J. Am. Chem. Soc. 1980, 10(6), 1837-1849.
46. MARSHALL, G.R., ARIMOTO, R., RAGNO, R., HEAD, R.D. Predicting affinity: the sina qua non of activity. Abstr. Pap. Am. Chem. Soc. 2000, 219, 056-COMP.
47. HEAD, R.D., SMYTHE, M.L., OPREA, T.I., WALLER, C.L., GREEN, S.M., MARSHALL, G.R. Validate - a new method for the receptor-based prediction of binding affinities of novel ligands. J. Am. Chem. Soc. 1996, 118(16), 3959-3969.
48. ZWANZIG, R., SZABO, A., BAGCHI, B. Levinthal's paradox. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 20-22.
49. KARPLUS, M. The Levinthal paradox: yesterday and today. Fold. Des. 1997, 2(4), S69-S75.
50. SIMONS, K.T., STRAUSS, C., BAKER, D. Prospects for ab initio protein structural genomics. J. Mol. Biol. 2001, 1191-1199.
51. BYSTROFF, C., BAKER, D. Prediction of local structure in proteins using a library of sequence-structure motifs. J. Mol. Biol. 1998, 281(3), 565-577.
52. SIMONS, K.T., BONNEAU, R., RUCZINSKI, I., BAKER, D. Ab initio protein structure prediction of CASP III targets using ROSETTA. Proteins 1999, 171-176.
53. KUHLMAN, B., DANTAS, G., IRETON, G.C., VARANI, G., STODDARD, B.L., BAKER, D. Design of a novel globular protein fold with atomic-level accuracy. Science 2003, 302(5649), 1364-1368.
54. GALAKTIONOV, S., NIKIFOROVICH, G.V., MARSHALL, G.R. Ab initio modeling of small, medium, and large loops in proteins. Biopolymers 2001, 60(2), 153-168.
55. GALAKTIONOV, S.G., MARSHALL, G.R. Properties of intraglobular contacts in proteins: an approach to prediction of tertiary structure. Proceedings of the 27th Hawaii International Conference on System Sciences. IEEE Computational Society, Washington, DC, 1994, 326-335.
56. BERGLUND, A., HEAD, R.D., WELSH, E., MARSHALL, G.R. ProVal: a protein scoring function for the selection of native and near-native folds. Proteins: Struct., Funct., Bioinf. 2004, 54, 289-302.
57. JONES, D.T., TAYLOR, W.R., THORNTON, J.M. A new approach to protein fold recognition. Nature 1992, 358, 86-89.
58. KUNTZ, I.D., BLANEY, J.M., OATLEY, S.J., LANGRIDGE, R., FERRIN, T.E. A Geometric Approach to Macromolecule-Ligand Interactions. J. Mol. Biol. 1982, 161, 269.
59. GOODSELL, D.S., LAUBLE, H., STOUT, C.D., OLSON, A.J. Automated docking in crystallography: analysis of the substrates of aconitase. Proteins: Struct., Funct., Genet. 1993, 17, 1-10.
60. MORRIS, G.M., GOODSELL, D.S., HALLIDAY, R.S., HUEY, R., HART, W.E., BELEW, R.K., OLSON, A.J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 1998, 19(14), 1639-1662.
61. MAKINO, S., EWING, T.J.A., KUNTZ, I.D. DREAM++: Flexible docking program for virtual combinatorial libraries. J. Comput.-Aided Mol. Des. 1999, 13(5), 513-532.
62. SHOICHET, B.K., LEACH, A.R., KUNTZ, I.D. Ligand solvation in molecular docking. Proteins 1999, 34(1), 4-16.
63. LAMB, M.L., BURDICK, K.W., TOBA, S., YOUNG, M.M., SKILLMAN, K.G., ZOU, X.Q., ARNOLD, J.R., KUNTZ, I.D. Design, docking, and evaluation of multiple libraries against multiple targets. Proteins: Struct., Funct., Genet. 2001, 42(3), 296-318.
64. ABAGYAN, R., TOTROV, M. High-throughput docking for lead generation. Curr. Opin. Chem. Biol. 2001, 5(4), 375-382.
65. CRIPPEN, G.M. Distance geometry and conformational calculations. In Chemometrics Research Studies, Vol. 1, BAWDEN, D. (ed.) John Wiley, Chichester, UK, 1981.
66. GOODFORD, P.J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Am. Chem. Soc. 1985, 28(7), 849-856.
67. RINGE, D. Structure-aided drug design: crystallography and computational approaches. J. Nucl. Med. 1995, 36 (6 Suppl), 28S-30S.
68. RINGE, D., MATTOS, C. Analysis of the binding surfaces of proteins. Med. Res. Rev. 1999, 19(4), 321-331.
69. SHUKER, S.B., HAJDUK, P.J., MEADOWS, R.P., FESIK, S.W. Discovering highaffinity ligands for proteins: SAR by NMR. Science 1996, 274(5292), 1531-1534.
70. HO, C.M., MARSHALL, G.R. Cavity search: an algorithm for the isolation and display of cavity-like binding regions. J. Comput. Aided Mol. Des. 1990, 4(4), 337-354.
71. HO, C.M.W., MARSHALL, G.R. SPLICE - a program to assemble partial query solutions from three-dimensional database searches into novel ligands. J. Comput.-Aided Mol. Des. 1993, 7(6), 623-647.
72. HO, C.M., MARSHALL, G.R. FOUNDATION: a program to retrieve all possible structures containing a user-defined minimum number of matching query elements from threedimensional databases. J. Comput. Aided Mol. Des. 1993, 7(1), 3-22.
73. HO, C.M.W. In silico lead optimization. In Chemoinformatics in Drug Discovery, OPREA, T.I. (ed.) Wiley-VCH, Weinheim, 2004, 199-219.
74. STOUCH, T.R., KENYON, J.R., JOHNSON, S.R., CHEN, X.-Q., DOWYKO, A., LI, Y. In silico ADME/Tox: why models fail. J. Comput.-Aided Drug Des. 2003, 17, 83-92.
75. OPREA, T.I., DAVIS, A.M., TEAGUE, S.J., LEESON, P.D. Is there a difference between leads and drugs? A historical perspective. J. Chem. Inf. Comput. Sci. 2001, 1308-1315.
76. OPREA, T.I. Current trends in lead discovery: Are we looking for the apporpriate properties? J. Comput.-Aided Drug Des. 2002, 16, 325-334.
77. KOPPAL, T. Pharmacology's resurrection. Drug Disc. Dev. 2003, 6(11), 28-32.
78. MERRIFIELD, R.B. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 1963, 2149-2154.
79. CARUTHERS, M.H. Gene synthesis machines: DNA chemistry and its uses. Science 1985, 230(4723), 281-285.
80. LEZNOFF, C.C. The use of insoluble polymer supports on general organic synthesis. Acc. Chem. Res. 1978, 11, 327-333.
81. BUNIN, B.A., ELLMAN, J.A. A general and expedient method for the solid-phase synthesis of 1,4-benzodiazepine derivatives. J. Am. Chem. Soc. 1992, 114, 10 997-10 998.
82. OPREA, T.I., MATTER, H. Integrating virtual screening in lead discovery. Curr. Opin. Chem. Biol. 2004, 8, 349-358.
83. STILL, W.C., TEMPCZYK, A., HAWLEY, R.C., HENDRICKSON, T. Semianalytical treatment of solvation for molecular mechanics and dynamics. J. Am. Chem. Soc. 1990, 112(16), 6127-6129.
84. WIREKO, F.C., KELLOGG, G.E., ABRAHAM, D.J. Allosteric modifiers of hemoglobin. 2. Crystallographically determined binding-sites and hydrophobic binding interaction analysis of novel hemoglobin oxygen effectors. J. Med. Chem. 1991, 34(2), 758-767.
85. ABRAHAM, D.J. Drug discovery in academia. In Chemoinformatics in Drug Discovery, OPREA, T.I. (ed.) Wiley-VCH, Weinheim, 2004, 457-484.